| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 183.99B | 214.37B | 196.52B | 185.19B | 153.47B | 162.74B |
| Gross Profit | 40.40B | 38.71B | 42.31B | 40.59B | 31.71B | 33.12B |
| EBITDA | 19.26B | 20.59B | 20.73B | 21.34B | 10.44B | 15.04B |
| Net Income | 7.04B | 4.76B | 8.21B | 8.18B | 4.58B | 6.21B |
Balance Sheet | ||||||
| Total Assets | 389.00B | 419.51B | 372.51B | 337.45B | 341.67B | 223.47B |
| Cash, Cash Equivalents and Short-Term Investments | 47.12B | 59.03B | 48.04B | 42.74B | 47.87B | 33.43B |
| Total Debt | 256.08B | 268.26B | 227.00B | 210.46B | 227.38B | 127.97B |
| Total Liabilities | 303.14B | 329.39B | 283.40B | 265.78B | 276.53B | 163.87B |
| Stockholders Equity | 79.93B | 84.11B | 83.28B | 65.99B | 61.60B | 59.31B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -26.24B | -13.13B | 9.29B | -20.26B | -2.50B |
| Operating Cash Flow | 0.00 | 5.60B | 7.88B | 36.78B | -722.00M | 23.19B |
| Investing Cash Flow | 0.00 | -31.94B | -24.81B | -26.33B | -46.35B | -27.87B |
| Financing Cash Flow | 0.00 | 37.20B | 22.04B | -15.46B | 61.53B | -1.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥36.77B | 5.76 | ― | 3.01% | 7.25% | 36.43% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
63 Neutral | ¥41.75B | 7.74 | ― | 6.02% | -5.07% | -26.79% | |
62 Neutral | ¥2.84T | 7.65 | 11.39% | 2.93% | 2.61% | 10.15% | |
59 Neutral | ¥6.18B | 12.20 | 2.90% | 4.53% | -12.48% | -34.07% | |
58 Neutral | ¥121.60B | 20.27 | 4.48% | 3.30% | 3.93% | 16.91% | |
56 Neutral | ¥55.61B | 11.83 | 6.98% | 7.35% | 9.08% | -42.76% |